.webp)
Cancer registries face mounting pressures — rising caseloads, shrinking resources, and increasing demands for timely, accurate data and mandated cancer reporting. Manual, fragmented software systems simply cannot keep pace, resulting in case reporting backlogs and staff burnout. Discover an end-to-end automated solution that introduces efficiency at scale at each step of the workflow, transforming how registries capture, manage, and leverage critical oncology data and mandated reporting.
From Compliance Burden to Strategic Asset: Transforming Cancer Registries with End-to-End Automation
The Case for Transformation
Cancer registry data plays an essential role in monitoring public health trends, supporting patient care, and advancing research that will lead to new treatments that improve outcomes. Delivering this critical clinical data in a timely manner, however, remains a significant challenge for many registries.
Today's cancer registries are consistently under pressure to comply with evolving mandates while managing growing caseloads—in fact, the CDC projects cancer cases to increase by nearly 50% from 2015 to 2050.1 Registries are routinely expected to do more with less, despite reduced budgets and staffing shortages. Further amplifying the problem, many registries find themselves grappling with fragmented clinical systems that demand tedious manual case review, data entry, and reporting (Figure 1). This inefficient approach creates a cascade of problems: case reporting backlogs, reimbursements, staff burnout, accreditation risks, and missed opportunities that could benefit patients and advance research.
Figure 1. An illustration of a cancer registry workflow where data is manually reviewed by an ODS to identify cases, then manually abstracted into the registry software, and entered again into the case reporting software.
The reality is that manual processes do not scale. As cancer incidence continues to rise, registries already struggling to keep pace with case finding and reporting will only fall further behind. To meet rising demands, registries need a different approach—a single, unified, end-to-end cancer registry solution that transforms the registry from a fragmented, high-cost compliance burden into a strategic asset that delivers real value.
An End-to-End Cancer Registry Solution
Registries need solutions that maximize efficiency and unleash their full potential. That's why Inspirata has partnered with ONCO to offer the only end-to-end cancer registry solution for oncology data management that automates routine tasks, freeing staff to focus on high-value work. Built by industry leaders with more than 60 years of combined experience in oncology informatics, our integrated cancer registry software—a combination of Inspirata’s E-Path/E-Path Plus software and ONCO’s ONCOLog software—enables automated casefinding, data abstraction, report submission, and data analysis—all in one seamless workflow (Figure 2).
Figure 2. Automated casefinding, data abstraction, and reporting enables ODSs to significantly reduce time spent on manual review and data entry, freeing them to work at the top of their license.
Inspirata’s 20+ years of expertise in the use of AI, NLP, and LLM applications has led to the development of a hybrid engine that powers our suite of oncology data management solutions. By applying the best technology to solve each problem area, incorporating logic for broader interpretation, and drawing upon domain-specific knowledge, our platform improves the accuracy of casefinding, data abstraction, and reporting, streamlines registry workflows, unlocks data to accelerate research, and transforms siloed data into a strategic asset for the entire oncology service line.
The Benefits of an Integrated Oncology Informatics Solution
Eliminates Inefficiency and Errors
By implementing one unified automated system, registries can significantly minimize the manual data entry and re-entry that occur during casefinding, abstraction, and reporting—a major source of error that can result in lost data and missed opportunities. E-Path is powered by a clinically validated AI/NLP/LLM engine that identifies reportable cancer cases from patient records in real-time with 99% accuracy, eliminating the need to review non-reportable cases. E-Path Plus further streamlines the process by automating data abstraction and pre-populating NAACCR data items.2 Data then flows automatically from E-Path Plus to the ONCOLog software, eliminating the potential for manual transfer errors and ensuring seamless continuity throughout the workflow.
Empowers Skilled Staff
Automating routine workflow tasks frees highly skilled Oncology Data Specialists (ODSs) from tedious, repetitive work, reducing burnout and allowing them to redirect their expertise toward high-value activities. Instead of spending hours on manual data entry, staff can focus on quality assurance, accreditation management, data analysis, clinical data support, and patient care. These activities better demonstrate the registry's clinical value to the organization and contribute to registry growth.
Creates a Single Source of Truth
A clean, uniform, and seamless infrastructure for data collection and analysis provides registries unparalleled confidence in their processes — from casefinding through reporting. This unified approach eliminates data silos and discrepancies that plague fragmented systems, creating a single reliable source of truth that powers compliance, clinical research initiatives, and administrative decision-making with accuracy and consistency.
Rethinking Cancer Registry Operations
Today, cancer registries face unprecedented challenges—rising caseloads, shrinking resources, and increasing demands for timely, accurate data. Manual, fragmented systems simply cannot keep pace with these mounting pressures. Registries need tools that introduce efficiency at scale at each step of the workflow, transforming how they capture, manage, and leverage critical oncology data.
With the Inspirata and ONCO end-to-end cancer registry solution for oncology data management, registries can move beyond survival mode and amplify their impact on clinical studies and research that will ultimately improve patient outcomes.
Contact us for a free workflow assessment. We’re here to find solutions that drive registry efficiency and growth.
References
- Weir, H.K., et al. Cancer Incidence Projections in the United States Between 2015 and 2050. Prev Chronic Dis 2021;18:210006.
- NAACCR Data Standards and Data Dictionary. https://apps.naaccr.org/data-dictionary/